E
Elke Bräuer-Krisch
Researcher at European Synchrotron Radiation Facility
Publications - 129
Citations - 4800
Elke Bräuer-Krisch is an academic researcher from European Synchrotron Radiation Facility. The author has contributed to research in topics: Dosimetry & Microbeam. The author has an hindex of 38, co-authored 126 publications receiving 4213 citations.
Papers
More filters
Journal ArticleDOI
X-rays can trigger the FLASH effect: Ultra-high dose-rate synchrotron light source prevents normal brain injury after whole brain irradiation in mice.
Pierre Montay-Gruel,Audrey Bouchet,Maud Jaccard,David Patin,Raphaël Serduc,Warren Aim,Kristoffer Petersson,Benoit Petit,Claude Bailat,Jean Bourhis,Elke Bräuer-Krisch,Marie-Catherine Vozenin +11 more
TL;DR: Results show that a 10 Gy whole-brain irradiation delivered at ultra-high dose-rate with synchrotron generated X-rays does not induce memory deficit; it reduces hippocampal cell-division impairment and induces less reactive astrogliosis.
Journal ArticleDOI
Toward an image-guided microbeam radiation therapy using gadolinium-based nanoparticles.
Géraldine Le Duc,Imen Miladi,Christophe Alric,Pierre Mowat,Elke Bräuer-Krisch,Audrey Bouchet,Enam A. Khalil,Claire Billotey,Marc Janier,François Lux,Thierry Epicier,Pascal Perriat,Stéphane Roux,Stéphane Roux,Olivier Tillement +14 more
TL;DR: GBNs exhibit an interesting potential for image-guided radiotherapy since the radiosensitizing effect of GBNs can be activated by X-ray microbeams when the gadolinium content is enough in the tumor and low in the surrounding healthy tissue.
Journal ArticleDOI
Effects of pulsed, spatially fractionated, microscopic synchrotron X-ray beams on normal and tumoral brain tissue.
Elke Bräuer-Krisch,Raphaël Serduc,E.A. Siegbahn,G. Le Duc,Yolanda Prezado,Alberto Bravin,Hans Blattmann,Jean A. Laissue +7 more
TL;DR: The paper highlights the history of MRT including salient biological findings after microbeam irradiation with emphasis on the vascular components and the tolerance of the central nervous system and details on experimental and theoretical dosimetry of microbeams, core issues and possible therapeutic applications of M RT are presented.
Journal ArticleDOI
Preferential effect of synchrotron microbeam radiation therapy on intracerebral 9L gliosarcoma vascular networks.
Audrey Bouchet,Benjamin Lemasson,Benjamin Lemasson,Géraldine Le Duc,Cécile Maisin,Cécile Maisin,Elke Bräuer-Krisch,E.A. Siegbahn,Luc Renaud,Luc Renaud,Enam A. Khalil,Chantal Rémy,Cathy Poillot,Alberto Bravin,Jean A. Laissue,Emmanuel L. Barbier,Raphaël Serduc +16 more
TL;DR: It is shown for the first time that preferential damage of MRT to tumor vessels versus preservation of radioresistant normal brain vessels contributes to the efficient palliation of 9L gliosarcomas in rats.
Journal ArticleDOI
Determination of dosimetrical quantities used in microbeam radiation therapy (MRT) with Monte Carlo simulations.
TL;DR: The ratio of peak-to-valley doses (PVDR's) in the composite dose distribution has been found to be strongly correlated with the normal tissue tolerance and the therapeutic effect of MRT.